Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
10-K/A

Amendment to a previously filed 10-K

Annual Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SC 13D/A

An amendment to a SC 13D filing

Other
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K

Report of unscheduled material events or corporate event

Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

Registration Statements
4

Statement of changes in beneficial ownership of securities

3,4,5
SC 13D/A

An amendment to a SC 13D filing

Other